Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia
- Status
- COMPLETED
- Phase
- PHASE1
Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia
- Status
- COMPLETED
- Phase
- NA
Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1
Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders
- Status
- COMPLETED
- Phase
- PHASE2
10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1